Document Migration

PRODUCTS

  • keyboard laptop virtual
    Medical Writing For Clinical Trials

    For successful regulatory outcomes, we provide quality medical writing services for clinical trial documents, safety updates, and marketing applications.

  • GettyImages-539843648 regulations doctor
    Manufacturing And Import License (MIA) And Batch Certification

    Navigating both the specific country and general European regulations and requirements to supply medicinal products to the European markets can be a complex challenge. This applies both to Marketing Authorisation Holders (MAH) of approved commercial medicinal products and Sponsors of clinical trials.

  • HPLC Chromatography laboratory scientist GettyImages-1309780330
    Analytical & Quality Control

    Learn how robust in-house analytical services and protein characterization are crucial for successful development and manufacturing programs.

  • GettyImages-1418357339-hand-spreadsheet-computer-keyboard
    Electronic Data Capture (EDC) System: Leverage Flexibility And Speed

    Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.

    They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.

    Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.

  • Cytiva Kubio
    Modular Environments For Biomanufacturing Capacity

    Accelerate your biomanufacturing capacity with purpose-built modules

    KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.

WHITE PAPERS AND CASE STUDIES

NEWS